Patents by Inventor Mark Behlke

Mark Behlke has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12378612
    Abstract: The present invention relates to a rapid detection of microbial-associated nuclease activity with chemically modified nuclease (e.g., endonuclease) substrates, and probes and compositions useful in detection assays.
    Type: Grant
    Filed: October 5, 2021
    Date of Patent: August 5, 2025
    Assignee: UNIVERSITY OF IOWA RESEARCH FOUNDATION
    Inventors: James O. McNamara, Katie R. Flenker, Hyeon Kim, Alexander R. Horswill, Frank J. Hernandez, Mark Behlke, Lingyan Huang, Richard Owczarzy, Elliot Burghardt, Karen Clark
  • Patent number: 12123033
    Abstract: Described herein are compositions and methods for improving homology directed repair (HDR) efficiency and reducing homology-independent integration following introduction of double strand breaks with engineered nucleases. Additionally, modifications to double stranded DNA donors to improve the donor potency and efficiency of homology directed repair following introduction of double stranded breaks with programmable nucleases.
    Type: Grant
    Filed: October 23, 2020
    Date of Patent: October 22, 2024
    Assignee: INTEGRATED DNA TECHNOLOGIES, INC.
    Inventors: Jessica Woodley, Bernice Thommandru, Joseph Dobosy, Mark Behlke, Adam Clore, Garrett Rettig, Beimeng Sun
  • Publication number: 20240309350
    Abstract: Described herein are compositions and methods for improving homology directed repair (HDR) efficiency and reducing homology-independent integration following introduction of double strand breaks with engineered nucleases. Additionally, modifications to double stranded DNA donors to improve the donor potency and efficiency of homology directed repair following introduction of double stranded breaks with programmable nucleases.
    Type: Application
    Filed: May 30, 2024
    Publication date: September 19, 2024
    Inventors: Jessica Woodley, Bernice Thommandru, Joseph Dobosy, Mark Behlke, Adam Clore, Garrett Rettig, Beimeng Sun
  • Publication number: 20240279722
    Abstract: Described herein are compositions and methods for the production and quantification of barcoded or unique molecular identifier (UMI)-labeled substrates. In one aspect, the substrate is a bead comprising a template oligonucleotide that is elongated by successive extension reactions to provide a bead with an oligonucleotide comprising a plurality of barcodes and conserved anchor regions. Methods are also described for quantifying the amount of template oligonucleotide loaded onto the substrate and the products of the extension reaction after each round and after the final extension.
    Type: Application
    Filed: April 16, 2024
    Publication date: August 22, 2024
    Inventors: Joseph DOBOSY, Scott D. ROSE, Jeffrey A. MANTHEY, Shawn D. ALLEN, Steven A. HENCK, Mark BEHLKE
  • Patent number: 12037615
    Abstract: Described herein are compositions and methods for improving homology directed repair (HDR) efficiency and reducing homology-independent integration following introduction of double strand breaks with engineered nucleases. Additionally, modifications to double stranded DNA donors to improve the donor potency and efficiency of homology directed repair following introduction of double stranded breaks with programmable nucleases.
    Type: Grant
    Filed: October 23, 2020
    Date of Patent: July 16, 2024
    Assignee: INTEGRATED DNA TECHNOLOGIES, INC.
    Inventors: Jessica Woodley, Bernice Thommandru, Joseph Dobosy, Mark Behlke, Adam Clore, Garrett Rettig, Beimeng Sun
  • Patent number: 11999994
    Abstract: Described herein are compositions and methods for the production and quantification of barcoded or unique molecular identifier (UMI)-labeled substrates. In one aspect, the substrate is a bead comprising a template oligonucleotide that is elongated by successive extension reactions to provide a bead with an oligonucleotide comprising a plurality of barcodes and conserved anchor regions. Methods are also described for quantifying the amount of template oligonucleotide loaded onto the substrate and the products of the extension reaction after each round and after the final extension.
    Type: Grant
    Filed: January 13, 2022
    Date of Patent: June 4, 2024
    Assignee: INTEGRATED DNA TECHNOLOGIES, INC.
    Inventors: Joseph Dobosy, Scott D. Rose, Jeffrey A. Manthey, Shawn D. Allen, Steven A. Henck, Mark Behlke
  • Publication number: 20220220545
    Abstract: Described herein are compositions and methods for the production and quantification of barcoded or unique molecular identifier (UMI)-labeled substrates. In one aspect, the substrate is a bead comprising a template oligonucleotide that is elongated by successive extension reactions to provide a bead with an oligonucleotide comprising a plurality of barcodes and conserved anchor regions. Methods are also described for quantifying the amount of template oligonucleotide loaded onto the substrate and the products of the extension reaction after each round and after the final extension.
    Type: Application
    Filed: January 13, 2022
    Publication date: July 14, 2022
    Inventors: Joseph DOBOSY, Scott D. ROSE, Jeffrey A. MANTHEY, Shawn D. ALLEN, Steven A. HENCK, Mark BEHLKE
  • Publication number: 20220098648
    Abstract: The present invention relates to a rapid detection of microbial-associated nuclease activity with chemically modified nuclease (e.g., endonuclease) substrates, and probes and compositions useful in detection assays.
    Type: Application
    Filed: October 5, 2021
    Publication date: March 31, 2022
    Applicant: UNIVERSITY OF IOWA RESEARCH FOUNDATION
    Inventors: James O. McNamara, Katie R. Flenker, Hyeon Kim, Alexander R. Howswill, Frank J. Hernandez, Mark Behlke, Lingyan Huang, Richard Owczarzy, Elliott Burghardt, Karen Clark
  • Patent number: 11155882
    Abstract: The present invention relates to a rapid detection of microbial-associated nuclease activity with chemically modified nuclease (e.g., endonuclease) substrates, and probes and compositions useful in detection assays.
    Type: Grant
    Filed: February 19, 2020
    Date of Patent: October 26, 2021
    Assignee: UNIVERSITY OF IOWA RESEARCH FOUNDATION
    Inventors: James O. McNamara, Katie R. Flenker, Hyeon Kim, Alexander R. Howswill, Frank J. Hernandez, Mark Behlke, Lingyan Huang, Richard Owczarzy, Elliott Burghardt, Karen Clark
  • Publication number: 20210123035
    Abstract: Described herein are compositions and methods for improving homology directed repair (HDR) efficiency and reducing homology-independent integration following introduction of double strand breaks with engineered nucleases. Additionally, modifications to double stranded DNA donors to improve the donor potency and efficiency of homology directed repair following introduction of double stranded breaks with programmable nucleases.
    Type: Application
    Filed: October 23, 2020
    Publication date: April 29, 2021
    Inventors: Jessica Woodley, Bernice Thommandru, Joseph Dobosy, Mark Behlke, Adam Clore, Garrett Rettig, Beimeng Sun
  • Patent number: 10982273
    Abstract: The invention is directed to methods and kits for performing an RNase H2-mediated cleavage reaction on a sample in an emulsion.
    Type: Grant
    Filed: August 9, 2017
    Date of Patent: April 20, 2021
    Assignee: Integrated DNA Technologies, Inc.
    Inventors: Joseph Dobosy, Sarah Jacobi, Richard Owczarzy, Mark Behlke, Jessica Lister
  • Publication number: 20200283830
    Abstract: The present invention relates to a rapid detection of microbial-associated nuclease activity with chemically modified nuclease (e.g., endonuclease) substrates, and probes and compositions useful in detection assays.
    Type: Application
    Filed: February 19, 2020
    Publication date: September 10, 2020
    Applicant: UNIVERSITY OF IOWA RESEARCH FOUNDATION
    Inventors: James O. McNamara, Katie R. Flenker, Hyeon Kim, Alexander R. Howswill, Frank J. Hernandez, Mark Behlke, Lingyan Huang, Richard Owczarzy, Elliott Burghardt, Karen Clark
  • Patent number: 10619219
    Abstract: The present invention relates to a rapid detection of microbial-associated nuclease activity with chemically modified nuclease (e.g., endonuclease) substrates, and probes and compositions useful in detection assays.
    Type: Grant
    Filed: February 9, 2015
    Date of Patent: April 14, 2020
    Assignee: University of Iowa Research Foundation
    Inventors: James O. McNamara, Katie R. Flenker, Hyeon Kim, Alexander R. Horswill, Frank J. Hernandez, Mark Behlke, Lingyan Huang, Richard Owczarzy, Elliot Burghardt, Karen Clark
  • Publication number: 20180142241
    Abstract: The invention is directed to compositions and methods for selectively reducing the expression of a gene product from a desired target gene in a cell, as well as for treating diseases caused by the expression of the gene. More particularly, the invention is directed to compositions that contain double stranded RNA (“dsRNA”), and methods for preparing them, that are capable of reducing the expression of target genes in eukaryotic cells. The dsRNA has a first oligonucleotide sequence that is between 25 and about 30 nucleotides in length and a second oligonucleotide sequence that anneals to the first sequence under biological conditions. In addition, a region of one of the sequences of the dsRNA having a sequence length of at least 19 nucleotides is sufficiently complementary to a nucleotide sequence of the RNA produced from the target gene to trigger the destruction of the target RNA by the RNAi machinery.
    Type: Application
    Filed: December 21, 2017
    Publication date: May 24, 2018
    Applicants: CITY OF HOPE, INTEGRATED DNA TECHNOLOGIES, INC.
    Inventors: John J. Rossi, Mark Behlke, Dongho Kim
  • Publication number: 20180044716
    Abstract: The invention is directed to methods and kits for performing an RNase H2-mediated cleavage reaction on a sample in an emulsion.
    Type: Application
    Filed: August 9, 2017
    Publication date: February 15, 2018
    Inventors: Joseph Dobosy, Sarah Jacobi, Richard Owczarzy, Mark Behlke
  • Publication number: 20170218438
    Abstract: The invention provides a more efficient and less error-prone method of performing LAMP. The invention also provides a method for utilizing an RNase H2-cleavable probe as a technique for generating signal from the reaction, potentially increasing the specificity of the signal generation.
    Type: Application
    Filed: February 1, 2017
    Publication date: August 3, 2017
    Applicant: Integrated DNA Technologies, Inc.
    Inventors: Joseph Dobosy, Aurita Menezes, Caifu Chen, Mark Behlke
  • Publication number: 20160340717
    Abstract: The present invention relates to a rapid detection of microbial-associated nuclease activity with chemically modified nuclease (e.g., endonuclease) substrates, and probes and compositions useful in detection assays.
    Type: Application
    Filed: February 9, 2015
    Publication date: November 24, 2016
    Applicant: UNIVERSITY OF IOWA RESEARCH FOUNDATION
    Inventors: James O. McNamara, Katie R. Flenker, Hyeon Kim, Alexander R. Horswill, Frank J. Hernandez, Mark Behlke, Lingyan Huang, Richard Owczarzy, Elliot Burghardt, Karen Clark
  • Patent number: 9081737
    Abstract: The present invention provides methods that more accurately predict melting temperatures for duplex oligomers. The invented methods predict the Tm of chimeric duplexes containing various amounts of locked nucleic acid modifications in oligonucleotide strands.
    Type: Grant
    Filed: July 29, 2011
    Date of Patent: July 14, 2015
    Assignee: Integrated DNA Technologies, Inc.
    Inventors: Mark Behlke, Richard Owczarzy, Scott D. Rose, Andrey Tataurov, Yong You
  • Publication number: 20150045410
    Abstract: The present invention relates to therapeutic agents comprising miR-138, a miR-138 mimic, a SIN3A RNAi molecule, or a an anti-SIN3A RNAi molecule, and/or an anti-SIN3A antisense oligonucleotide (ASO) or other agent that suppresses SIN3A expression, a small molecule drug that interferes with SIN3A activity or whose actions mimic the biological effects of SIN3A suppression and methods of use of these therapeutic agents to treat cystic fibrosis.
    Type: Application
    Filed: February 6, 2013
    Publication date: February 12, 2015
    Inventors: Paul McCray, Shyam Ramachandran, Yi Xing, Michael Welsh, Mark Behlke
  • Patent number: 8258276
    Abstract: A compound having the general formula shown below: where R1-6 are independently selected from the group consisting of an electron withdrawing group, an alkyl group, an aryl group, hydrogen, a heteroaryl group, and a five or six member ring structure formed from the R1 and R2 pair, the R3 and R4 pair, the R4 and R5 pair, or the R5 and R6 pair; R7 is a substituted or unsubstituted aryl group; and Y is a nucleophile.
    Type: Grant
    Filed: September 2, 2011
    Date of Patent: September 4, 2012
    Assignee: Integrated DNA Technologies, Inc.
    Inventors: Andrei Laikhter, Joseph A. Walder, Mark Behlke, Mikhail Podyminogin, Yawfui Yong